Intraocular lens delivery device
Latest Novartis AG Patents:
- Tricyclic AKR1C3 dependent KARS inhibitors
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Methods of treating HIV-HAART induced partial lipodystrophy with FGF21 protein variant FC fusion proteins
- Solid forms comprising an oxime ether compound, compositions and methods of use thereof
- Urea compounds and compositions as SMARCA2/BRM ATPase inhibitors
Description
The broken lines on the lever and sides of the intraocular lens delivery device represent surface texture features superimposed on continuous surfaces of the lever and the sides of the intraocular lens delivery device. These surface texture features, along with the other features shown in broken lines in the figures, form no part of the claimed design.
Claims
The ornamental design for an intraocular lens delivery device, as shown and described.
Referenced Cited
U.S. Patent Documents
7563222 | July 21, 2009 | Larsen |
D612052 | March 16, 2010 | McCollam |
D642266 | July 26, 2011 | Marsteller |
D669582 | October 23, 2012 | Weston |
D686728 | July 23, 2013 | Chen |
D727512 | April 21, 2015 | Baker |
D731060 | June 2, 2015 | Little, III |
D737966 | September 1, 2015 | Meguro |
D747796 | January 19, 2016 | Romao |
D752749 | March 29, 2016 | Van Dalen |
D773651 | December 6, 2016 | Chen |
D775723 | January 3, 2017 | Rowe |
D788909 | June 6, 2017 | Ratjen |
D789536 | June 13, 2017 | Korenfeld |
9724191 | August 8, 2017 | Auld |
20010008950 | July 19, 2001 | Vitali |
20040077919 | April 22, 2004 | Drobnik |
20070055089 | March 8, 2007 | Larsen |
20090112258 | April 30, 2009 | Kreidler |
20150282928 | October 8, 2015 | Auld et al. |
20160015511 | January 21, 2016 | Auld et al. |
20160067036 | March 10, 2016 | Auld |
20170119522 | May 4, 2017 | Auld |
Patent History
Patent number: D841164
Type: Grant
Filed: Dec 16, 2015
Date of Patent: Feb 19, 2019
Assignee: Novartis AG (Basel)
Inventors: Matthew Flowers (Lake Forest, CA), Matthew McCawley (Lake Forest, CA), John Huculak (Lake Forest, CA), Jack Auld (Lake Forest, CA), David Weston (Lake Forest, CA), Marshall Proulx (Lake Forest, CA), Chris Mudd (Fort Worth, TX), Ahmet Tezel (Fort Worth, TX)
Primary Examiner: Lakiya G Rogers
Assistant Examiner: Carissa C Fitts
Application Number: 29/548,755
Type: Grant
Filed: Dec 16, 2015
Date of Patent: Feb 19, 2019
Assignee: Novartis AG (Basel)
Inventors: Matthew Flowers (Lake Forest, CA), Matthew McCawley (Lake Forest, CA), John Huculak (Lake Forest, CA), Jack Auld (Lake Forest, CA), David Weston (Lake Forest, CA), Marshall Proulx (Lake Forest, CA), Chris Mudd (Fort Worth, TX), Ahmet Tezel (Fort Worth, TX)
Primary Examiner: Lakiya G Rogers
Assistant Examiner: Carissa C Fitts
Application Number: 29/548,755
Classifications
Current U.S. Class:
Ophthalmic (D24/150)